{
      "brief_title": [
            "compare",
            "3",
            "schedule",
            "alimta",
            "plus",
            "gemzar"
      ],
      "brief_summary": [
            "purpose",
            "study",
            "measure",
            "tumor",
            "response",
            "rat",
            "three",
            "schedule",
            "alimta",
            "combination",
            "gemcitabine",
            "patient",
            "locally",
            "advance",
            "metastatic",
            "non",
            "small",
            "cell",
            "lung",
            "cancer",
            "receive",
            "prior",
            "chemotherapy",
            "regimen"
      ],
      "condition": [
            "lung",
            "neoplasm"
      ],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "Pemetrexed (Alimta) in combination with gemcitabine (Gemzar)"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "diagnosis",
            "lung",
            "cancer",
            "prior",
            "chemotherapy",
            "able",
            "care",
            "self",
            "exclusion",
            "criterion",
            "ongoing",
            "infection",
            "pregnancy",
            "breast",
            "feed",
            "serious",
            "medical",
            "condition",
            "cancer",
            "spread",
            "brain",
            "inability",
            "take",
            "folic",
            "acid"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "keyword": [
            "chemotherapy"
      ],
      "mesh_term": [
            "lung",
            "neoplasm"
      ],
      "id": "NCT00034606"
}